Larotin, Fe S.
HRN: 22-25-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/29/2022
12/05/2022
IV
600mg
Q8
Bleeding & Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes